Darin Scribner, DO
Pain Medicine · Napoleon, OHNPI 1154717585
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. SPR Therapeutics, Inc accounts for 88.1% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $9,801, more than ten times the $718 reported in 2020.
Across 48 payments — averaging $233.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SPR Therapeutics, Inc$10K
- Boston Scientific$829
- Medtronic$138
- Relievant Medsystems, Inc.$131
- AbbVie$119
- Stimwave Technologies Incorporated$69
- plus $47 from 2 others
What the payments were for
- Consulting fees$5,61050%
- Travel & lodging$4,28438%
- Food & beverage$1,29912%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SPR Therapeutics, Inc | 23 | $9,862 |
| Boston Scientific | 11 | $829 |
| Medtronic(2 entities) | 3 | $138 |
| Relievant Medsystems, Inc. | 1 | $131 |
| AbbVie(2 entities) | 6 | $119 |
| Stimwave Technologies Incorporated | 1 | $69 |
| Abbott | 2 | $29 |
| Averitas Pharma Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,193 in reported general payments places this provider in the 80th percentile of 245 pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 16 | $2,453 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 81 | $1,585 |
| Gabapentin | 109 | $1,431 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 65 | $1,160 |
| Cyclobenzaprine Hcl | 39 | $748 |
| Pregabalin | 29 | $747 |
| Duloxetine Hcl | 12 | $562 |
| Oxycodone Hcl | 32 | $454 |
| Etodolac | 17 | $402 |
| Tramadol Hcl | 44 | $209 |
| Tizanidine Hcl | 27 | $207 |
| Celecoxib | 14 | $184 |
| Baclofen | 16 | $101 |
| Methocarbamol | 13 | $88 |
| Methylprednisolone | 13 | $81 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Napoleon
- Alexander EscobarToledo$638K
- Nagy MekhailCleveland$511K
- Henry VuceticWilloughby$509K
- Tammy DannDayton$431K
- Michael DankoLoveland$381K
- Jonathan SilvermanDayton$234K
- Tristan WeaverColumbus$202K
- Robert BolashCleveland$154K
- Dmitri SouzaCuyahoga Falls$61K
- Aman UpadhyayCleveland$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.